JP2010280669A5 - - Google Patents

Download PDF

Info

Publication number
JP2010280669A5
JP2010280669A5 JP2010157000A JP2010157000A JP2010280669A5 JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5 JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
independently
case
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010157000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010280669A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010280669A publication Critical patent/JP2010280669A/ja
Publication of JP2010280669A5 publication Critical patent/JP2010280669A5/ja
Withdrawn legal-status Critical Current

Links

JP2010157000A 2002-05-21 2010-07-09 置換複素環式化合物および使用方法 Withdrawn JP2010280669A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38269902P 2002-05-21 2002-05-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004507465A Division JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Publications (2)

Publication Number Publication Date
JP2010280669A JP2010280669A (ja) 2010-12-16
JP2010280669A5 true JP2010280669A5 (OSRAM) 2011-10-06

Family

ID=29584444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法
JP2010157000A Withdrawn JP2010280669A (ja) 2002-05-21 2010-07-09 置換複素環式化合物および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Country Status (10)

Country Link
US (1) US7026326B2 (OSRAM)
EP (1) EP1506186A1 (OSRAM)
JP (2) JP4606161B2 (OSRAM)
AR (1) AR039842A1 (OSRAM)
AU (1) AU2003234628B2 (OSRAM)
CA (1) CA2485166A1 (OSRAM)
MX (1) MXPA04011470A (OSRAM)
PL (1) PL376575A1 (OSRAM)
TW (1) TW200406399A (OSRAM)
WO (1) WO2003099808A1 (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2533684A1 (en) 2003-07-25 2005-02-10 Amgen Inc. Substituted pyridones and pyrimidinones with antiinflammatory properties
AU2004267096B2 (en) * 2003-08-20 2008-10-02 Amgen Inc. Substituted pyrimdinone derivatives and methods of use
MX2007007553A (es) * 2004-12-24 2007-08-15 Prosidion Ltd Agonistas del receptor acoplado a proteina g (gpr116) y uso de los mismos para tratar obesidad y diabetes.
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
US8062824B2 (en) * 2006-07-17 2011-11-22 E. I. Du Pont De Nemours And Company Thermally imageable dielectric layers, thermal transfer donors and receivers
US7528448B2 (en) * 2006-07-17 2009-05-05 E.I. Du Pont De Nemours And Company Thin film transistor comprising novel conductor and dielectric compositions
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EP2203439B1 (en) 2007-09-14 2011-01-26 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
US7666567B2 (en) 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Negative imaging method for providing a patterned metal layer having high conductivity
US7666568B2 (en) * 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Composition and method for providing a patterned metal layer having high conductivity
MX2011002042A (es) 2008-09-02 2011-06-20 Ortho Mcneil Janssen Pharm Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2430022B1 (en) 2009-05-12 2013-11-20 Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
JP5707390B2 (ja) 2009-05-12 2015-04-30 ジャンセン ファーマシューティカルズ, インコーポレイテッド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP6085866B2 (ja) 2011-02-28 2017-03-01 アレイ バイオファーマ、インコーポレイテッド セリン/トレオニンキナーゼインヒビター
BR112014002675A2 (pt) 2011-08-04 2017-02-21 Array Biopharma Inc "quinazolina como inibidores de serina/treonina quinase, seus usos, e composição"
WO2013066729A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
PL2820009T3 (pl) * 2012-03-01 2018-09-28 Array Biopharma, Inc. Inhibitory kinaz serynowo/treoninowych
CA2882750A1 (en) 2012-08-27 2014-03-06 Jim Blake Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
AU2015208233B2 (en) 2014-01-21 2019-08-29 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US11178870B2 (en) * 2017-04-11 2021-11-23 Mitsui Chemicals Agro, Inc. Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients
KR102730718B1 (ko) * 2017-08-23 2024-11-14 스프린트 바이오사이언스 아베 피리딜피리돈 화합물
ES2929424T3 (es) * 2017-08-23 2022-11-29 Sprint Bioscience Ab Compuestos de piridinamina-piridona y pirimidinamina-piridona
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
JP2023553809A (ja) 2020-11-25 2023-12-26 デシフェラ・ファーマシューティカルズ,エルエルシー ウイルス感染の治療に使用するためのvsp34阻害剤としてのピリジルピリドン誘導体
EP4444305A2 (en) * 2022-02-16 2024-10-16 Duke Street Bio Limited Pharmaceutical compound
EP4626878A1 (en) 2022-12-02 2025-10-08 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
WO1995009917A1 (en) 1993-10-07 1995-04-13 The Regents Of The University Of California Genetically engineered bispecific tetravalent antibodies
EP1621206A1 (en) 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
DE69739656D1 (de) 1996-02-09 2009-12-31 Amgen Inc 1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
CN1328277C (zh) * 1996-12-05 2007-07-25 安姆根有限公司 取代的嘧啶酮和吡啶酮化合物和它们的应用
JP2002514195A (ja) * 1996-12-05 2002-05-14 アムジエン・インコーポレーテツド 置換ピリミジン化合物およびそれの使用
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6410729B1 (en) * 1996-12-05 2002-06-25 Amgen Inc. Substituted pyrimidine compounds and methods of use
ES2615357T3 (es) 1996-12-06 2017-06-06 Amgen Inc. Terapia de combinación usando un inhibidor de IL-1 para tratar enfermedades mediadas por IL-1
KR19980066046A (ko) 1997-01-18 1998-10-15 정용훈 고역가의 CTLA4-Ig 융합단백질
ATE223229T1 (de) 1997-04-17 2002-09-15 Amgen Inc Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
WO2002074753A2 (de) * 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen

Similar Documents

Publication Publication Date Title
JP2010280669A5 (OSRAM)
JP2012092103A5 (OSRAM)
JP2013102146A5 (ja) 化合物
JP2015042636A5 (ja) 有機化合物
JP2013040159A5 (ja) 有機金属錯体
JP2016503300A5 (OSRAM)
JP2014500861A5 (OSRAM)
JP2010241801A5 (OSRAM)
JP2015505296A5 (OSRAM)
JP2011121940A5 (ja) 発光素子
JP2010254680A5 (ja) 複素環化合物、及び発光素子
JP2016540742A5 (OSRAM)
JP2013542218A5 (OSRAM)
JP2010095546A5 (OSRAM)
JP2011528706A5 (OSRAM)
JP2010523522A5 (OSRAM)
JP2012109092A5 (OSRAM)
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
JP2012109091A5 (OSRAM)
JP2013147496A5 (ja) 有機金属錯体
JP2014509612A5 (OSRAM)
JP2014526533A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2012523419A5 (OSRAM)
JP2012140436A5 (ja) 物質